As the FDA began issuing denials, Vapetasia CEO Chris Finch started planning. He knew the next step was to sue the FDA, but he also knew it would take money, manpower, and risk.
There was also an overwhelming sense of déjà vu. The unchecked enthusiasm, the stacks of gray-market goods, the casual dismissal of potential consequences—it all felt eerily reminiscent of the early 2010s, a time when explosive growth blinded many to the risks they were taking.
Kayla Kurnik built a name for herself in cannabis, but staying in the industry hasn’t always been easy. From navigating a male-dominated space to setting her own value, she’s learned what it takes to succeed on her own terms.